Hong Jiang

Title: Innovations in Pancreatic Cancer Diagnosis by Hong Jiang

Introduction

Hong Jiang is an accomplished inventor based in Chengdu, China. He has made significant contributions to the field of medical diagnostics, particularly in the area of pancreatic cancer. His innovative approach focuses on the application of mechanical-force sensitive macrophages as a diagnostic and prognostic tool for pancreatic cancer.

Latest Patents

Hong Jiang holds a patent titled "Application of mechanical-force sensitive macrophage subset in pancreatic cancer diagnosis or prognosis evaluation." This patent reveals that the number of mechanical force sensitive macrophages, specifically CD68p-PYK2YAP1, is significantly higher in pancreatic cancer tissues compared to adjacent normal tissues. The presence of these macrophages correlates positively with the progression of pancreatic cancer, indicating their potential as a diagnostic and prognostic index. Furthermore, the research highlights that inhibiting the mechanical force checkpoint PYK2 in monocytes/macrophages reduces the elasticity modulus of the cells, thereby improving the tumor microenvironment and remarkably inhibiting the growth of pancreatic cancer.

Career Highlights

Throughout his career, Hong Jiang has focused on innovative research that bridges the gap between mechanical biology and cancer diagnostics. His work has garnered attention for its potential to improve patient outcomes through early detection and targeted treatment strategies.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Hong Jiang's innovative research and patent on mechanical-force sensitive macrophages represent a significant advancement in the diagnosis and prognosis of pancreatic cancer. His contributions have the potential to enhance the understanding and treatment of this challenging disease.